Activepassive International Equity ETF (APIE)

N/A +N/A (N/A)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund is an actively-managed exchange-traded fund (“ETF”) that blends active and passive investment strategies to optimize costs, tracking and potential return over the fund’s benchmark index, the S&P Classic ADR Composite Index. Under normal market conditions, the fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities of non-U.S. companies with varying market capitalizations.

OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 26 at 11:56 AM
$APIE RSI: 64.20, MACD: 0.2261 Vol: 0.30, MA20: 35.04, MA50: 34.77 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 28 at 1:03 PM
Ryanair Pulls Plug On Prime Membership Offering After Trial Proves Too Costly $RYAAY $APIE $CGGR https://stocktwits.com/news/equity/markets/ryanair-pulls-plug-on-prime-membership-offering-after-trial-proves-too-costly/cL5aRnaRELJ
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 25 at 12:18 PM
Novo Nordisk’s Experimental GLP-1 Drug Shows Weight Loss, Blood Sugar Levels Reduction In Study $NVO $DFAX $APIE https://stocktwits.com/news/equity/markets/novo-nordisk-experimental-glp-1-drug-shows-weight-loss-blood-sugar-level-reduction-in-study/cL52hCvREXo
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 24 at 11:49 AM
Novo Nordisk’s Blockbuster Drug Fails To Slow Alzheimer’s Disease Progression In Studies $NVO $DFAX $APIE https://stocktwits.com/news/equity/markets/novo-nordisk-blockbuster-drug-fails-to-slow-alzheimers-disease-progression-in-studies/cL5bIRrREQT
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 5 at 1:22 PM
Why Did BioNTech Stock Surge 10% Pre-Market Today? $BNTX $APIE $TCAF https://stocktwits.com/news/equity/markets/why-is-biontech-rising-pre-market-today/chwIXnPRdqb
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 4 at 12:54 PM
Sanofi’s New Experimental Eczema Drug Meets Goals Of Late-stage Trial, But Wall Street Expected More $SNY $DFAX $APIE https://stocktwits.com/news/equity/markets/sanofi-experimental-eczema-drug-meets-goals-of-late-stage-trial/chwddprRdYk
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 11 at 6:36 PM
Novartis Fails To Block Heart Failure Drug’s Generic From Launching Through 2026: Report $NVS $DFAX $APIE https://stocktwits.com/news/equity/markets/novartis-fails-to-block-heart-failure-drugs-generic-from-launching-through-2026-report/ch8cmAbR5Ne
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 8 at 11:44 AM
Novartis Gets Swiss Authority Nod For First Malaria Drug In Newborns, Young Infants $NVS $DFAX $APIE https://stocktwits.com/news/equity/markets/novartis-gets-swiss-authority-nod-for-first-malaria-drug-in-newborns-young-infants/chFvYaxR5gZ
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 3 at 1:00 PM
Novartis’ Blockbuster Drug Fails Late-Stage Trial In Disease Causing Blood Vessel Inflammation, But Retail Turns Bullish $NVS $DFAX $APIE https://stocktwits.com/news/equity/markets/novartis-drug-fails-late-stage-trial-in-disease-causing-blood-vessel-inflammation/chFjsnERcNX
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 18 at 5:24 PM
US Judge Upholds FDA Decision To Remove Wegovy, Ozempic From Shortage List In Move Against Compounding Pharmacies $NVO $AVDE $APIE https://stocktwits.com/news/equity/markets/us-judge-upholds-fda-decision-to-remove-wegovy-ozempic-from-shortage-list/chlsO9tRR20
0 · Reply
Latest News on APIE
No data available.
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 26 at 11:56 AM
$APIE RSI: 64.20, MACD: 0.2261 Vol: 0.30, MA20: 35.04, MA50: 34.77 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 28 at 1:03 PM
Ryanair Pulls Plug On Prime Membership Offering After Trial Proves Too Costly $RYAAY $APIE $CGGR https://stocktwits.com/news/equity/markets/ryanair-pulls-plug-on-prime-membership-offering-after-trial-proves-too-costly/cL5aRnaRELJ
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 25 at 12:18 PM
Novo Nordisk’s Experimental GLP-1 Drug Shows Weight Loss, Blood Sugar Levels Reduction In Study $NVO $DFAX $APIE https://stocktwits.com/news/equity/markets/novo-nordisk-experimental-glp-1-drug-shows-weight-loss-blood-sugar-level-reduction-in-study/cL52hCvREXo
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 24 at 11:49 AM
Novo Nordisk’s Blockbuster Drug Fails To Slow Alzheimer’s Disease Progression In Studies $NVO $DFAX $APIE https://stocktwits.com/news/equity/markets/novo-nordisk-blockbuster-drug-fails-to-slow-alzheimers-disease-progression-in-studies/cL5bIRrREQT
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 5 at 1:22 PM
Why Did BioNTech Stock Surge 10% Pre-Market Today? $BNTX $APIE $TCAF https://stocktwits.com/news/equity/markets/why-is-biontech-rising-pre-market-today/chwIXnPRdqb
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 4 at 12:54 PM
Sanofi’s New Experimental Eczema Drug Meets Goals Of Late-stage Trial, But Wall Street Expected More $SNY $DFAX $APIE https://stocktwits.com/news/equity/markets/sanofi-experimental-eczema-drug-meets-goals-of-late-stage-trial/chwddprRdYk
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 11 at 6:36 PM
Novartis Fails To Block Heart Failure Drug’s Generic From Launching Through 2026: Report $NVS $DFAX $APIE https://stocktwits.com/news/equity/markets/novartis-fails-to-block-heart-failure-drugs-generic-from-launching-through-2026-report/ch8cmAbR5Ne
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 8 at 11:44 AM
Novartis Gets Swiss Authority Nod For First Malaria Drug In Newborns, Young Infants $NVS $DFAX $APIE https://stocktwits.com/news/equity/markets/novartis-gets-swiss-authority-nod-for-first-malaria-drug-in-newborns-young-infants/chFvYaxR5gZ
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 3 at 1:00 PM
Novartis’ Blockbuster Drug Fails Late-Stage Trial In Disease Causing Blood Vessel Inflammation, But Retail Turns Bullish $NVS $DFAX $APIE https://stocktwits.com/news/equity/markets/novartis-drug-fails-late-stage-trial-in-disease-causing-blood-vessel-inflammation/chFjsnERcNX
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 18 at 5:24 PM
US Judge Upholds FDA Decision To Remove Wegovy, Ozempic From Shortage List In Move Against Compounding Pharmacies $NVO $AVDE $APIE https://stocktwits.com/news/equity/markets/us-judge-upholds-fda-decision-to-remove-wegovy-ozempic-from-shortage-list/chlsO9tRR20
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 12 at 6:44 PM
Novo Nordisk’s Plan To Start Late-Stage Trial Of Investigational Obesity Drug Amycretin In 2026 Gets Retail Talking $NVO $AVDE $APIE https://stocktwits.com/news/equity/markets/novo-nordisk-to-start-late-stage-trial-of-investigational-obesity-drug-in-2026/chlg4jxRRG7
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 12 at 3:21 PM
Mesoblast Gives Positive Update About Potential FDA Application For Heart Failure Therapy: Retail Sees ‘Inflection Point’ $MESO $APIE $IBBQ https://stocktwits.com/news/equity/markets/mesoblast-gives-positive-update-about-potential-fda-application-for-revascor/chlgT5lRb6z
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 11 at 3:16 PM
Novo Nordisk’s $812M Deal With Deep Apple Lifts Retail Mood, Chatter Spikes To High Levels $NVO $AVDE $APIE https://stocktwits.com/news/equity/markets/novo-nordisk-inks-812-million-deal-wth-deep-apple-therapeutics/chlaHHKRbCH
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 3 at 11:43 AM
WeRide Partners With Renault To Provide Autonomous Shuttle At The French Open, But Retail’s Not Excited $WRD $APIE $CARZ https://stocktwits.com/news/equity/markets/weride-partners-with-renault-for-autonomous-shuttle-service-at-the-french-open/chkr56IRbvO
0 · Reply
StocktwitsNews
StocktwitsNews May. 23 at 6:44 PM
Roche Gets Positive Opinion For Approval Of Cancer Therapy In EU: Retail Yet To React $RHHBY $APIE https://stocktwits.com/news/equity/markets/roche-gets-positive-opinion-for-cancer-therapy-approval-in-eu/ch0QAlNRbAP
0 · Reply
StocktwitsNews
StocktwitsNews May. 22 at 3:54 PM
Novo Nordisk To Sell Wegovy For $199 A Month As Compounding Ban Nears: Retail’s Bullish $NVO $AVDE $APIE https://stocktwits.com/news/equity/markets/novo-nordisk-to-sell-wegovy-for-199-dollars-month/ch09LwrRbpA
0 · Reply
StocktwitsNews
StocktwitsNews May. 21 at 3:59 PM
WeRide Narrows Losses In Q1, Announces $100M Share Repurchase Program: Retail’s Thrilled $WRD $APIE $CARZ https://stocktwits.com/news/equity/markets/weride-narrows-losses-in-q1-announces-share-repurchase/ch0e7vqRbYZ
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 8 at 3:17 PM
Sony Stock Jumps Pre-Market As Profit Booms Nearly 70%: Retail Buzz Builds. $SONY $AVDE $APIE $AVIV https://stevents.onelink.me/wmCS/nhqpzbu4
0 · Reply